Overview

Our History

Leadership Team

Partner

Portfolio Advisory Board

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Our Science

Peer Reviewed Publications

Presentations

2026 ADA Poster

GK Charger: An LLM-Empowered Knowledge Platform for Interactive Education in Glucokinase-Based Diabetes Therapy

2026 ADA Poster

A Novel ATP-Independent Enzymatic Cycling System for Glucose Removal Enables Accurate Quantification of 1,5-anhydroglucitol

2026 ADA Poster

Structural Mechanisms and AI-Driven Prediction of Glucokinase Variants: Advancing Precision Medicine in MODY2

2026 ADA Poster

Synergistic Effects of Dorzagliatin and Chiglitazar on Metabolic in DIO Mice with MASLD

2026 ADA Poster

Synergistic Metabolic and Hepatic Benefits of Dorzagliatin and Resmetirom in MASLD Mice

2026 ADA Poster

Development of Preliminary Predictive Models for Dorzagliatin Treatment Response and Diabetes Remission in Type 2 Diabetes: A Focus on Personalized Medicine

About Us

Overview

Our History

Leadership Team

Portfolio Advisory Board

Partner

Media center

Research & Development

Inovation

Dorzagliatin

mGluR5

Presentations

Peer Reviewed Publications

Media

Company News

Media Releases

Video

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Careers

Culture

Join Us

Products&Pipeline

Pipeline

HuaTangNing(华堂宁®)

Focus Us

沪公网安备 31011502013809号 Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.